Skip to main content
20 April 2025
Last updated:
Wednesday 16 April 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Cancer (Oncology)
Cancer (Oncology)
Innate Pharma's anti-cancer platform attracts BMS investment
Read more
Vaccinating against the tumour vasculature
Read more
An analysis of 2010 oncology drug failures
Read more
Immunocore pioneers new safety studies
Read more
Review of oncology in 2010
Read more
The peptide route to therapeutic cancer vaccines
Read more
Analysis of Special Protocol Assessments for oncology
Read more
A good beginning in the perilous biotech business
Read more
Transgene in vanguard of oncolytic virus therapy
Read more
US Special Protocol Assessments for Oncology
Read more
Pagination
Previous page
‹‹
Page 14
Next page
››
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form